Infectious Diseases

New systematic review and meta-analysis provides reassuring evidence for parents.

Most hearing loss resolves after viral illness, but make sure to follow up with patients after an ear infection.

Have you kept up with the latest NACI guidance?

National Advisory Committee on Immunization issues preliminary guidance on COVID-19 booster doses for 2023.

Despite intensive public health efforts to grind the COVID-19 pandemic to a halt, the recent emergence of the highly transmissible, extensively drug-resistant and profoundly immune system-evading XBB.1.5 SARS-CoV-2 subvariant is putting the global community on edge.

Healthcare professionals should be aware of the drug’s limitations against newer variants—and make sure they communicate them clearly to patients.

Although study results have been conflicting, overall evidence does not support use of fluvoxamine for current treatment of mild to moderate COVID-19.

Pediatric COVID-19 working group of AMMI Canada issues practice point on the treatment of acute COVID-19 in children.